(Q46976515)

27 December 2017

title

Evaluation of enalapril+losartan treatment with cardiopulmonary exercise test in patients with left ventricular dysfunction (English)

1 reference

27 December 2017

main subject

ventricular dysfunction

1 reference

Tamer Akbulut

1

1 reference

27 December 2017

Haldun Akgöz

2

1 reference

27 December 2017

Sennur Unal Dayi

3

1 reference

27 December 2017

Seden Erten Celik

4

1 reference

27 December 2017

Ufuk Gürkan

5

1 reference

27 December 2017

Gülşah Tayyareci

6

1 reference

27 December 2017

publication date

1 March 2006

1 reference

27 December 2017

published in

Angiology

1 reference

27 December 2017

volume

57

1 reference

27 December 2017

issue

2

1 reference

27 December 2017

page(s)

181-186

1 reference

27 December 2017

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970605700207

10.1177/000331970605700207

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017